ATRX and neoplasm: Tumors of the T2 subtype frequently harbored DAXX/ATRX mutations, as well as carrying 80% of mutations in the mTOR pathway genes, had a higher tumor mutation burden and longer telomeres, and presented a high frequency of alternative lengthening of telomeres.